Thomas Birkballe Hansen

VP & Head, Research at Targovax

Thomas Hansen has over 15 years of experience in academic research. Before joining Targovax he worked as an assistant professor at Aarhus University where he led a research team focusing on RNA biology and bioinformatics. In 2011, Thomas Hansen pioneered the discovery of circular RNA in human cells, and later in 2013 published the first functional characterization of circular RNA in Nature.

Location

Central Jutland, Denmark

Links


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Targovax

Targovax (OSE: TRVX) is a clinical-stage biotechnology company developing immune activators to target hard-to-treat solid tumors.


Industries

Headquarters

Oslo, Norway

Employees

11-50

Links